South, East India accounted for 67% of heatwave days in 2023
Business Standard|June 07, 2024
The number of heatwave days in east and southern peninsular India during peak summer in 2023 almost doubled and accounted for nearly two-thirds of the total heatwave days experienced across the country, the latest data released by the National Statistical Office (NSO) showed.
SHIVA RAJORA
South, East India accounted for 67% of heatwave days in 2023

It comes even as the total number of heat wave days across the country declined by more than 40 per cent to 111 days in 2023 from 190 in the preceding year.

The latest environment data by NSO shows that among the 24 states and Union Territories, Bihar (18 days) has the most number of heatwave days in 2023, up from 6 days in 2022.

It was followed by Andhra Pradesh (15 days), Odisha (15 days), Jharkhand (13 days), West Bengal (8 days) and Tamil Nadu (6 days). These six states accounted for 67 per cent of the total heat wave days in 2023.

Diese Geschichte stammt aus der June 07, 2024-Ausgabe von Business Standard.

Starten Sie Ihre 7-tägige kostenlose Testversion von Magzter GOLD, um auf Tausende kuratierte Premium-Storys sowie über 8.000 Zeitschriften und Zeitungen zuzugreifen.

Diese Geschichte stammt aus der June 07, 2024-Ausgabe von Business Standard.

Starten Sie Ihre 7-tägige kostenlose Testversion von Magzter GOLD, um auf Tausende kuratierte Premium-Storys sowie über 8.000 Zeitschriften und Zeitungen zuzugreifen.

WEITERE ARTIKEL AUS BUSINESS STANDARDAlle anzeigen
CDSCO cracks whip on drug units
Business Standard

CDSCO cracks whip on drug units

Shuts down 36% of the 400-odd drug manufacturing facilities for failing to meet quality standards

time-read
2 Minuten  |
June 28, 2024
Business Standard

USFDA flags drug quality concerns in India

The Center for Drug Evaluation and Research (CDER), a division of the US Food and Drug Administration (FDA), has expressed concern over the quality of drugs manufactured in India, asserting that it found violations at 11 per cent of the facilities it inspected in the country, the highest in any other global region, a senior official said.

time-read
1 min  |
June 28, 2024
Arundhati Roy gets UK's Pen Pinter Prize
Business Standard

Arundhati Roy gets UK's Pen Pinter Prize

Booker Prize-winning author Arundhati Roy, currently facing the threat of prosecution over historic comments on Kashmir 14 years ago, was on Thursday honoured with the prestigious Pen Pinter Prize 2024 for her \"unflinching and unswerving\" writings.

time-read
1 min  |
June 28, 2024
7 YEARS OF GST: MONTHLY COLLECTIONS SURGE 87%
Business Standard

7 YEARS OF GST: MONTHLY COLLECTIONS SURGE 87%

With enhanced revenues, the stage seems set for GST 2.0

time-read
5 Minuten  |
June 28, 2024
Launches may offer shot in arm for GSK Pharma
Business Standard

Launches may offer shot in arm for GSK Pharma

The stock of GlaxoSmithKline Pharmaceuticals, or GSK Pharma, has risen over 5 per cent in a week.

time-read
2 Minuten  |
June 28, 2024
Business Standard

700% surge in 6 mths: 25 SME stocks reach for the sky

Stocks of small and medium enterprises (SME) have had a good run at the bourses, with select counters surging more than 700 per cent in calendar year 2024, according to data from ACE Equity.

time-read
2 Minuten  |
June 28, 2024
Business Standard

Allied Blenders' IPO subscribed 23.5 times

Allied Blenders & Distillers's initial public offering (IPO) was subscribed 23.5 times on Thursday, the concluding day of the issue.

time-read
1 min  |
June 28, 2024
'Tax relief will be big positive for markets'
Business Standard

'Tax relief will be big positive for markets'

All eyes are on Union Budget proposals that will in July show the policy intent of the new government.

time-read
3 Minuten  |
June 28, 2024
Business Standard

Fairfax group divests 9.7% stake in CSB Bank

Canadian billionaire Prem Watsa's Fairfax group on Thursday divested a 9.7 per cent stake in CSB Bank through its arm FIH Mauritius Investments.

time-read
1 min  |
June 28, 2024
Dr Reddy's in pink of health after Haleon's NRT biz acquisition
Business Standard

Dr Reddy's in pink of health after Haleon's NRT biz acquisition

Dr Reddy's Laboratories (DRL) is set to acquire Haleon's global portfolio of consumer healthcare brands in the nicotine replacement therapy (NRT) category outside of the US.

time-read
2 Minuten  |
June 28, 2024